Japan Vaccines Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Vaccines market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Pfizer Inc

    • SANOFI SA

    • NOVARTIS AG.

    • Astellas Pharma Inc

    • Merck & Co. Inc

    • AstraZeneca

    • Merck & Co Inc.

    • SANOFI S.A

    • Emergent BioSolutions

    • Takeda Pharmaceuticals


    By Type:

    • Inactivated vaccines

    • DNA vaccines

    • Attenuated vaccines

    • Subunit vaccines

    • Conjugate vaccines

    • Toxoid vaccines

    • Others


    By End-User:

    • Infectious diseases

    • Cancer

    • Autism

    • Allergy

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Vaccines Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Vaccines Market Size and Growth Rate of Inactivated vaccines from 2014 to 2026

      • 1.3.2 Japan Vaccines Market Size and Growth Rate of DNA vaccines from 2014 to 2026

      • 1.3.3 Japan Vaccines Market Size and Growth Rate of Attenuated vaccines from 2014 to 2026

      • 1.3.4 Japan Vaccines Market Size and Growth Rate of Subunit vaccines from 2014 to 2026

      • 1.3.5 Japan Vaccines Market Size and Growth Rate of Conjugate vaccines from 2014 to 2026

      • 1.3.6 Japan Vaccines Market Size and Growth Rate of Toxoid vaccines from 2014 to 2026

      • 1.3.7 Japan Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Vaccines Market Size and Growth Rate of Infectious diseases from 2014 to 2026

      • 1.4.2 Japan Vaccines Market Size and Growth Rate of Cancer from 2014 to 2026

      • 1.4.3 Japan Vaccines Market Size and Growth Rate of Autism from 2014 to 2026

      • 1.4.4 Japan Vaccines Market Size and Growth Rate of Allergy from 2014 to 2026

      • 1.4.5 Japan Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Vaccines Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of Inactivated vaccines

      • 3.4.2 Market Size and Growth Rate of DNA vaccines

      • 3.4.3 Market Size and Growth Rate of Attenuated vaccines

      • 3.4.4 Market Size and Growth Rate of Subunit vaccines

      • 3.4.5 Market Size and Growth Rate of Conjugate vaccines

      • 3.4.6 Market Size and Growth Rate of Toxoid vaccines

      • 3.4.7 Market Size and Growth Rate of Others


    4 Segmentation of Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Vaccines in Infectious diseases

      • 4.4.2 Market Size and Growth Rate of Vaccines in Cancer

      • 4.4.3 Market Size and Growth Rate of Vaccines in Autism

      • 4.4.4 Market Size and Growth Rate of Vaccines in Allergy

      • 4.4.5 Market Size and Growth Rate of Vaccines in Others


    5 Market Analysis by Regions

    • 5.1 Japan Vaccines Production Analysis by Regions

    • 5.2 Japan Vaccines Consumption Analysis by Regions


    6 Hokkaido Vaccines Landscape Analysis

    • 6.1 Hokkaido Vaccines Landscape Analysis by Major Types

    • 6.2 Hokkaido Vaccines Landscape Analysis by Major End-Users


    7 Tohoku Vaccines Landscape Analysis

    • 7.1 Tohoku Vaccines Landscape Analysis by Major Types

    • 7.2 Tohoku Vaccines Landscape Analysis by Major End-Users


    8 Kanto Vaccines Landscape Analysis

    • 8.1 Kanto Vaccines Landscape Analysis by Major Types

    • 8.2 Kanto Vaccines Landscape Analysis by Major End-Users


    9 Chubu Vaccines Landscape Analysis

    • 9.1 Chubu Vaccines Landscape Analysis by Major Types

    • 9.2 Chubu Vaccines Landscape Analysis by Major End-Users


    10 Kinki Vaccines Landscape Analysis

    • 10.1 Kinki Vaccines Landscape Analysis by Major Types

    • 10.2 Kinki Vaccines Landscape Analysis by Major End-Users


    11 Chugoku Vaccines Landscape Analysis

    • 11.1 Chugoku Vaccines Landscape Analysis by Major Types

    • 11.2 Chugoku Vaccines Landscape Analysis by Major End-Users


    12 Shikoku Vaccines Landscape Analysis

    • 12.1 Shikoku Vaccines Landscape Analysis by Major Types

    • 12.2 Shikoku Vaccines Landscape Analysis by Major End-Users


    13 Kyushu Vaccines Landscape Analysis

    • 13.1 Kyushu Vaccines Landscape Analysis by Major Types

    • 13.2 Kyushu Vaccines Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Pfizer Inc

      • 14.1.1 Pfizer Inc Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 SANOFI SA

      • 14.2.1 SANOFI SA Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 NOVARTIS AG.

      • 14.3.1 NOVARTIS AG. Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Astellas Pharma Inc

      • 14.4.1 Astellas Pharma Inc Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Merck & Co. Inc

      • 14.5.1 Merck & Co. Inc Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 AstraZeneca

      • 14.6.1 AstraZeneca Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Merck & Co Inc.

      • 14.7.1 Merck & Co Inc. Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 SANOFI S.A

      • 14.8.1 SANOFI S.A Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Emergent BioSolutions

      • 14.9.1 Emergent BioSolutions Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Takeda Pharmaceuticals

      • 14.10.1 Takeda Pharmaceuticals Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 148 Figures and 167 Tables)

     

    • Figure Japan Vaccines Market Size and Growth Rate of Inactivated vaccines from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of DNA vaccines from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Attenuated vaccines from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Subunit vaccines from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Conjugate vaccines from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Toxoid vaccines from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Infectious diseases from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Autism from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Allergy from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Inactivated vaccines

    • Figure Market Size and Growth Rate of DNA vaccines

    • Figure Market Size and Growth Rate of Attenuated vaccines

    • Figure Market Size and Growth Rate of Subunit vaccines

    • Figure Market Size and Growth Rate of Conjugate vaccines

    • Figure Market Size and Growth Rate of Toxoid vaccines

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Vaccines by Different End-Users from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Infectious diseases from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Autism from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Allergy from 2014 to 2026

    • Figure Japan Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Vaccines Production by Regions

    • Table Japan Vaccines Production Share by Regions

    • Figure Japan Vaccines Production Share by Regions in 2014

    • Figure Japan Vaccines Production Share by Regions in 2018

    • Figure Japan Vaccines Production Share by Regions in 2026

    • Table Japan Vaccines Consumption by Regions

    • Table Japan Vaccines Consumption Share by Regions

    • Figure Japan Vaccines Consumption Share by Regions in 2014

    • Figure Japan Vaccines Consumption Share by Regions in 2018

    • Figure Japan Vaccines Consumption Share by Regions in 2026

    • Table Hokkaido Vaccines Consumption by Types from 2014 to 2026

    • Table Hokkaido Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Vaccines Consumption Share by Types in 2014

    • Figure Hokkaido Vaccines Consumption Share by Types in 2018

    • Figure Hokkaido Vaccines Consumption Share by Types in 2026

    • Table Hokkaido Vaccines Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Vaccines Consumption Share by End-Users in 2014

    • Figure Hokkaido Vaccines Consumption Share by End-Users in 2018

    • Figure Hokkaido Vaccines Consumption Share by End-Users in 2026

    • Table Tohoku Vaccines Consumption by Types from 2014 to 2026

    • Table Tohoku Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Vaccines Consumption Share by Types in 2014

    • Figure Tohoku Vaccines Consumption Share by Types in 2018

    • Figure Tohoku Vaccines Consumption Share by Types in 2026

    • Table Tohoku Vaccines Consumption by End-Users from 2014 to 2026

    • Table Tohoku Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Vaccines Consumption Share by End-Users in 2014

    • Figure Tohoku Vaccines Consumption Share by End-Users in 2018

    • Figure Tohoku Vaccines Consumption Share by End-Users in 2026

    • Table Kanto Vaccines Consumption by Types from 2014 to 2026

    • Table Kanto Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Kanto Vaccines Consumption Share by Types in 2014

    • Figure Kanto Vaccines Consumption Share by Types in 2018

    • Figure Kanto Vaccines Consumption Share by Types in 2026

    • Table Kanto Vaccines Consumption by End-Users from 2014 to 2026

    • Table Kanto Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Vaccines Consumption Share by End-Users in 2014

    • Figure Kanto Vaccines Consumption Share by End-Users in 2018

    • Figure Kanto Vaccines Consumption Share by End-Users in 2026

    • Table Chubu Vaccines Consumption by Types from 2014 to 2026

    • Table Chubu Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Chubu Vaccines Consumption Share by Types in 2014

    • Figure Chubu Vaccines Consumption Share by Types in 2018

    • Figure Chubu Vaccines Consumption Share by Types in 2026

    • Table Chubu Vaccines Consumption by End-Users from 2014 to 2026

    • Table Chubu Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Vaccines Consumption Share by End-Users in 2014

    • Figure Chubu Vaccines Consumption Share by End-Users in 2018

    • Figure Chubu Vaccines Consumption Share by End-Users in 2026

    • Table Kinki Vaccines Consumption by Types from 2014 to 2026

    • Table Kinki Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Kinki Vaccines Consumption Share by Types in 2014

    • Figure Kinki Vaccines Consumption Share by Types in 2018

    • Figure Kinki Vaccines Consumption Share by Types in 2026

    • Table Kinki Vaccines Consumption by End-Users from 2014 to 2026

    • Table Kinki Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Vaccines Consumption Share by End-Users in 2014

    • Figure Kinki Vaccines Consumption Share by End-Users in 2018

    • Figure Kinki Vaccines Consumption Share by End-Users in 2026

    • Table Chugoku Vaccines Consumption by Types from 2014 to 2026

    • Table Chugoku Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Vaccines Consumption Share by Types in 2014

    • Figure Chugoku Vaccines Consumption Share by Types in 2018

    • Figure Chugoku Vaccines Consumption Share by Types in 2026

    • Table Chugoku Vaccines Consumption by End-Users from 2014 to 2026

    • Table Chugoku Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Vaccines Consumption Share by End-Users in 2014

    • Figure Chugoku Vaccines Consumption Share by End-Users in 2018

    • Figure Chugoku Vaccines Consumption Share by End-Users in 2026

    • Table Shikoku Vaccines Consumption by Types from 2014 to 2026

    • Table Shikoku Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Vaccines Consumption Share by Types in 2014

    • Figure Shikoku Vaccines Consumption Share by Types in 2018

    • Figure Shikoku Vaccines Consumption Share by Types in 2026

    • Table Shikoku Vaccines Consumption by End-Users from 2014 to 2026

    • Table Shikoku Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Vaccines Consumption Share by End-Users in 2014

    • Figure Shikoku Vaccines Consumption Share by End-Users in 2018

    • Figure Shikoku Vaccines Consumption Share by End-Users in 2026

    • Table Kyushu Vaccines Consumption by Types from 2014 to 2026

    • Table Kyushu Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Vaccines Consumption Share by Types in 2014

    • Figure Kyushu Vaccines Consumption Share by Types in 2018

    • Figure Kyushu Vaccines Consumption Share by Types in 2026

    • Table Kyushu Vaccines Consumption by End-Users from 2014 to 2026

    • Table Kyushu Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Vaccines Consumption Share by End-Users in 2014

    • Figure Kyushu Vaccines Consumption Share by End-Users in 2018

    • Figure Kyushu Vaccines Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of SANOFI SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SANOFI SA

    • Figure Sales and Growth Rate Analysis of SANOFI SA

    • Figure Revenue and Market Share Analysis of SANOFI SA

    • Table Product and Service Introduction of SANOFI SA

    • Table Company Profile and Development Status of NOVARTIS AG.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NOVARTIS AG.

    • Figure Sales and Growth Rate Analysis of NOVARTIS AG.

    • Figure Revenue and Market Share Analysis of NOVARTIS AG.

    • Table Product and Service Introduction of NOVARTIS AG.

    • Table Company Profile and Development Status of Astellas Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc

    • Table Product and Service Introduction of Astellas Pharma Inc

    • Table Company Profile and Development Status of Merck & Co. Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co. Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co. Inc

    • Figure Revenue and Market Share Analysis of Merck & Co. Inc

    • Table Product and Service Introduction of Merck & Co. Inc

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Merck & Co Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc.

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc.

    • Figure Revenue and Market Share Analysis of Merck & Co Inc.

    • Table Product and Service Introduction of Merck & Co Inc.

    • Table Company Profile and Development Status of SANOFI S.A

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SANOFI S.A

    • Figure Sales and Growth Rate Analysis of SANOFI S.A

    • Figure Revenue and Market Share Analysis of SANOFI S.A

    • Table Product and Service Introduction of SANOFI S.A

    • Table Company Profile and Development Status of Emergent BioSolutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions

    • Table Product and Service Introduction of Emergent BioSolutions

    • Table Company Profile and Development Status of Takeda Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Product and Service Introduction of Takeda Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.